Anez G, McGarry A, Woo W, Kotloff KL, et al. Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: A phase 3, randomized, placebo-controlled trial (PREVENT-19). Vaccine 2025;61:127362.
PMID: 40479932